Table 2.
Demographics and clinical characteristics of SARS-CoV-2 infected patients and uninfected controls.
|
SARS-CoV-2 PCR |
|||||
|---|---|---|---|---|---|
| Variable |
Negative |
Positive |
|||
| N = 25 (36%)a | N = 44 (64%) a | p-value b | |||
| Maternal Age (years) | 35 | (34, 36) | 32 | (28, 39) | 0.2 |
| Gestational age (weeks) | 39.3 | (28.6, 40.0) | 39 | (37.3, 29.6) | 0.11 |
| BMI | 23 | (22, 25) | 28 | (24, 32) | 0.006 |
| unknown | 4 | 13 | |||
| Ethnicity | 0.4 | ||||
| Hispanic | 2 | 8% | 7 | 16% | |
| Non-Hispanic | 15 | 60% | 19 | 43% | |
| Unknown | 8 | 32% | 18 | 41% | |
| Race | 0.3 | ||||
| Asian | 3 | 12% | 4 | 9.1% | |
| Black | 3 | 12% | 6 | 14% | |
| other/declined | 3 | 12% | 14 | 32% | |
| White | 16 | 64% | 20 | 45% | |
| Admitted For | |||||
| Scheduled birth | 12 | 48% | 15 | 34% | 0.3 |
| Covid Symptoms | 0 | 0% | 4 | 9.1% | 0.3 |
| Other | 1 | 4% | 6 | 14% | 0.4 |
| Rupture of membranes | 6 | 24% | 6 | 14% | 0.3 |
| Active Labor | 6 | 24% | 16 | 36% | 0.3 |
| Pre-eclampsia | 2 | 8% | 5 | 11% | >0.9 |
| Comorbidities | |||||
| None | 13 | 52% | 32 | 73% | 0.082 |
| Diabetes | 2 | 8% | 4 | 9.1% | >0.9 |
| Hypertension | 2 | 8% | 7 | 16% | 0.5 |
| Autoimmune/Rheumatologic | 3 | 12% | 0 | 0% | 0.044 |
| Asthma | 3 | 12% | 4 | 9.1% | 0.7 |
| Cardiac Disease | 2 | 8% | 1 | 2.3% | 0.3 |
| Hematologic | 0 | 0% | 2 | 4.5% | 0.5 |
| Obstetric Co-morbidities | |||||
| None | 22 | 88% | 35 | 80% | 0.5 |
| Anomaly | 0 | 0% | 1 | 2.3% | >0.9 |
| Preterm Labor/Birth | 0 | 0% | 3 | 6.8% | 0.5 |
| Pre-eclampsia | 1 | 4% | 4 | 9.1% | 0.6 |
| Multiple-Gestation | 2 | 8% | 2 | 4.5% | 0.6 |
| Intrauterine Growth Restriction | 0 | 0% | 1 | 2.3% | >0.9 |
a
N (%)
b
Fisher's exact test; Wilcoxon rank sum exact test; Wilcoxon rank sum test; Pearson's Chi-squared test